COMPANY SUMMARY
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Financial Summary
| Share Statistics |
ELV |
Industry Median |
Percentile (All Stocks) |
| Market Cap (Mil) |
$81,629.6 |
$1,875.0 |
96% |
|
| Shares Out (Mil) |
217.9 |
77.1 |
78% |
|
| Institutional Ownership |
99.9% |
88.9% |
96% |
|
| Float (Mil) |
216.4 |
50.3 |
75% |
|
| Beta |
0.68 |
0.86 |
39% |
|
| Avg Daily Volume (000s) |
1,318 |
466 |
75% |
|
Price Change (52-week) |
30.4% |
78.5% |
69% |
|
| Growth |
ELV |
Industry Median |
Percentile (All Stocks) |
| Sales (5yr) |
10.3% |
10.9% |
59% |
|
| Net Income (5yr) |
4.4% |
(1.1%) |
46% |
|
| EPS (5yr) |
7.0% |
3.0% |
41 |
|
| Dividends (5yr) |
12.5% |
0.0% |
99% |
|
| Cash Flow (5yr) |
10.8% |
(18.2%) |
70% |
|
| Estimates |
Qtrly |
Current Fiscal Year |
Next Fiscal Year |
| # of Estimates |
19 |
20 |
21 |
| Current EPS |
$4.665 |
$27.158 |
$29.634 |
| Month Ago EPS |
$5.086 |
$26.903 |
$29.248 |
| # Rev Up |
0 |
1 |
1 |
| # Rev Down |
1 |
0 |
0 |
| Three Months Ago EPS |
$5.097 |
$26.906 |
$29.225 |
| Year/Year Chg |
(30.5%) |
7.7% |
34.9% |
| Financials |
ELV |
Industry Median |
Percentile (All Stocks) |
| Sales (TTM) (Mil) |
$201,114 |
$1,464 |
100% |
|
| Net Income (TTM) (Mil) |
$4,963 |
$15 |
97% |
|
| EPS (TTM) |
$22.528 |
$0.300 |
98% |
|
| Operating Cash Flow (TTM) (Mil) |
$7,464 |
$138 |
97% |
|
| Net Cash Flow (TTM) (Mil) |
$1,672 |
$7 |
97% |
|
| Long-Term Debt (Q1) (Mil) |
$30,669 |
$323 |
97% |
|
| Enterprise Value (Q1) (Mil) |
$101,867 |
$2,130 |
96% |
|
| Valuation |
ELV |
Industry Median |
Percentile (All Stocks) |
| P/B |
1.82 |
2.90 |
48% |
|
| P/E |
16.7 |
26.8 |
41% |
|
| Dividend Yield |
1.8% |
0.0% |
74% |
|
| PEG (5yr hist) |
2.4 |
1.1 |
72% |
|
| Ratios |
ELV |
Industry Median |
Percentile (All Stocks) |
| Gross Margin |
26.0% |
27.6% |
29% |
|
| Net Margin |
2.5% |
1.1% |
40% |
|
| ROA |
4.0% |
1.8% |
67% |
|
| ROE |
11.2% |
6.9% |
61% |
|
| Liabilities to Assets |
64.4% |
60.0% |
59% |
|
| F-Score |
6 |
5 |
69% |
|
Passing Stock Screens
As of 7/30/2026, from a list of 60 stock screening strategies,
ELV meetings the criteria of 2 screen:
Stock Screen
FACTOR STRATEGY
P/E Relative Screen
Factors: Value, Earnings Estimates
A screen that looks at the relationship of a stock's price-earnings ratio to that of the industry and market.